Rapid Micro Biosystems

« Previous article
Automation and LIMs ...

15th June 2022  Content supplied by: Rapid Micro Biosystems

Looking to Accelerate Your Pharma 4.0 Journey?

As the industry continues the Pharma 4.0 journey, achieving a successful digital transition for product manufacturing is critical. Enhancements to laboratory system and software connectivity provides an opportunity to automate data collection and analysis, enhance data integrity, and eliminate risk of human error within your quality control (QC) microbiology programs. Get Rapid Micro Biosystems’ expert perspective on the digital landscape and LIMS integration by downloading our latest article featuring a Q&A with Kham Nguyen on Pharma 4.0, LIMS Integration, and System Validation.

Kham Nguyen, Director of Validations at Rapid Micro Biosystems, has helped many of the world’s leading pharmaceutical manufacturers validate the Growth Direct® System in their QC microbiology labs during the past decade. In this question-and-answer session, Nguyen discusses digitalization and laboratory information management systems (LIMS) integration.

If you have any questions or would like more information, visit us at Rapid Micro Biosystems or click on the Request Information button below.

Share on:


Date Published: 15th June 2022

Source article link: View

View full company details

Rapid Micro Biosystems



United States

Tel: +[1] 978 349 3200

Email Supplier

View full company details

Related news from Rapid Micro Biosystems